Paloma Partners’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,600
Closed -$956K 1404
2022
Q2
$903K Buy
20,600
+18,099
+724% +$995K 0.03% 452
2022
Q1
$181K Sell
2,501
-13,756
-85% -$992K 0.01% 1444
2021
Q4
$1.32M Buy
16,257
+7,495
+86% +$751K 0.02% 580
2021
Q3
$1.02M Buy
+8,762
New +$1.15M 0.03% 340
2020
Q4
Sell
-9,904
Closed -$1.38M 2334
2020
Q3
$1.38M Buy
9,904
+6,663
+206% +$890K 0.03% 544
2020
Q2
$387K Buy
3,241
+40
+1% +$4.74K 0.01% 1349
2020
Q1
$320K Buy
+3,201
New +$385K 0.02% 658
2018
Q4
Sell
-5,429
Closed -$310K 1851
2018
Q3
$310K Buy
+5,429
New +$339K 0.01% 1217
2018
Q2
Sell
-2,553
Closed -$221K 2311
2018
Q1
$221K Buy
+2,553
New +$206K ﹤0.01% 1765
2017
Q2
Sell
-9,937
Closed -$931K 2488
2017
Q1
$931K Buy
+9,937
New +$900K 0.01% 1273

Other funds holding NVRO

Paloma Partners's NVRO Position: Q3 2022 in Review

Paloma Partners sold out of NEVRO CORP. (NVRO) in Q3 2022, closing a stake of 20,600 shares — an estimated $956K sold.

Paloma Partners first reported a position in NVRO in Q1 2017 and held it in 10 quarters. The position peaked at $1.38M in Q3 2020. 176 funds tracked by Wall St. Rank hold NVRO as of Q3 2022.

  • Paloma Partners reported no remaining NEVRO CORP. position as of Q3 2022 after selling out during the quarter.
  • Paloma Partners sold 20,600 NEVRO CORP. shares in Q3 2022, an estimated $956K.
  • Paloma Partners first reported a position in NEVRO CORP. in Q1 2017 and held it in 10 quarters.
  • Paloma Partners's NEVRO CORP. position peaked at $1.38M in Q3 2020.
  • 176 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2022.

Based on Paloma Partners's 13F filing for Q3 2022, filed 14 Nov 2022.